Medgenics (MDGN) Misses Q1 EPS by 8c

Medgenics (NYSE: MDGN) reported Q1 EPS of ($0.34), $0.08 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Medgenics (MDGN) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Lowe's slashes full-year sales outlook amid DIY spending pressure